Stefan Fasbender supports the Life Sciences investment team as analyst since July 2020. The medical physicist is a scholar of the Düsseldorf School of Oncology and worked as research assistant at the solid-state physics laboratory of HHU Düsseldorf. There, he studied the possible applications of carbon-based nanoparticles with focus on drug delivery and established a close cooperation between the departments of physics, chemistry and medicine. This research work resulted in several publications in renowned journals.
+49 – (0) 228 – 82300 – 193